AARTIDRUGS.NS

Aarti Drugs Limited · Healthcare · Drug Manufacturers-Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$43.31B

PE Ratio

21.186986563065886

EV to Ebitda

—

Earnings Yield

390475558.43%

Revenue (TTM)

$322.5M

Net Income (TTM)

$20.0M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

4.60%

Profit Margin

6.21%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

0.00%

All fundamentals

Core6 fields›

Market Cap$43.31B

Revenue TTM$322.5M

Shares Outstanding92.6M

Float34200279

Insider Ownership66.19%

Institutional Ownership5.04%

Growth Estimates3 fields›

Revenue Growth (Quarterly YoY)4.60%

EPS Growth (Quarterly YoY)-37.00%

EPS Growth Est Quarterly0

Operations14 fields›

Revenue TTM$322.5M

Gross Margin TTM29.48%

Gross Margin (Quarterly)30.28%

Operating Margin TTM9.36%

Operating Margin (Quarterly)8.74%

Profit Margin TTM6.21%

Profit Margin (Quarterly)5.52%

Net Income TTM$20.0M

EPS TTM17.69

EBIT Margin TTM11.16%

EBITDA TTM$36.0M

Capex % of Revenue TTM8.65%

Capital Expenditures$27.9M

FCF % of Revenue (Quarterly)-3.09%

Efficiency1 fields›

ROA8.25%

Valuation6 fields›

P/E (TTM)21.186986563065886

P/E Forward0

EV/Revenues (TTM)1.8145

Earnings Yield390475558.43%

Dividend Yield0.00%

Payout Ratio5.59%

Liquidity3 fields›

Cash Per Share3.7764578833693303

Current Ratio1.4822139012403464

Interest Expense$305.7M

Yields3 fields›

Dividend Yield0.00%

Payout Ratio5.59%

Earnings Yield390475558.43%